Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 2;11(10):1347. doi: 10.3390/antibiotics11101347

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Pharmacological options to treat secondary peritonitis by carbapenem-resistant pathogens. Notes: AZAV-aztreonam/avibactam; CAZ- ceftazidime/avibactam; CFD-cefideclor; CPT-ceftaroline; CRO-ceftriaxone; CT- ceftolozane/tazobactam; CTX-cefotaxime; DAP-daptomicine; EV-everacicline; FOF-fosfomicine; GEN-gentamicin; MD-metronidazole; MEM-meropenem; MV-meropenem/vaborbactam; PLA-plazomycin; PXB-polymyxin B; PXE-polymyxin E; RIC-relebactam/imipenem/cilastatin; TG-tigecycline; TPZ-piperacillin/tazobactam; VitC-ascorbic acid. *not in monotherapy.